Calidi Biotherapeutics (Calidi Biotherapeutics) Operating Cash Flow per Share : $-0.11 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Operating Cash Flow per Share?

Calidi Biotherapeutics's operating cash flow per share for the three months ended in Mar. 2024 was $-0.11. Calidi Biotherapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.11.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -128.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Calidi Biotherapeutics's Operating Cash Flow per Share or its related term are showing as below:

CLDI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -128.5 Med: -128.5 Max: -128.5
Current: -128.5

During the past 4 years, Calidi Biotherapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -128.50% per year. The lowest was -128.50% per year. And the median was -128.50% per year.

CLDI's 3-Year OCF Growth Rate is ranked worse than
97.89% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs CLDI: -128.50

Calidi Biotherapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Calidi Biotherapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Operating Cash Flow per Share Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-0.13

-0.22

-0.37

-1.60

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial					-0.09	-	-	-	-0.11

Competitive Comparison of Calidi Biotherapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Calidi Biotherapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calidi Biotherapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calidi Biotherapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Calidi Biotherapeutics's Price-to-Operating-Cash-Flow falls into.

Calidi Biotherapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Calidi Biotherapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-26.983	/	16.887
	=	-1.60

Calidi Biotherapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-3.831	/	35.552
	=	-0.11

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11

Calidi Biotherapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024